Literature DB >> 14743908

Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study.

Alessandro Frati1, Maurizio Salvati, Fabrizio Mainiero, Flora Ippoliti, Giovanni Rocchi, Antonino Raco, Emanuela Caroli, Giampaolo Cantore, Roberto Delfini.   

Abstract

OBJECT: To evaluate the role of local inflammation in the pathogenesis and postoperative recurrence of chronic subdural hematoma (CSDH), the authors conducted an investigation in a selected group of patients who could clearly recall a traumatic event and who did not have other risk factors for CSDH. Inflammation was analyzed by measuring the concentration of the proinflammatory and inflammatory cytokines interleukin (IL)-6 and IL-8. The authors also investigated the possible relationship between high levels of local inflammation that were measured and recurrence of the CSDH.
METHODS: A prospective study was performed between 1999 and 2001. Thirty-five patients who could clearly recall a traumatic event that had occurred at least 3 weeks previously and who did not have risk factors for CSDH were enrolled. All patients were surgically treated by burr hole irrigation plus external drainage. The concentration of inflammatory cytokines was very high in the lesion, whereas it was normal in serum. In five cases in which recurrence occurred, concentrations of both IL-6 and IL-8 were significantly increased (p < 0.01) in comparison with cases without a recurrence. In a layering hematoma, the IL-6 and IL-8 concentrations were significantly higher (p < 0.05). Layering CSDHs were also significantly correlated with recurrence. Trabecular hematoma had the lowest cytokine levels and the longest median interval between trauma and clinical onset. The interval from trauma did not significantly influence recurrence, although it did differ significantly between the trabecular and layering CSDH groups. Concentrations of IL-6 and IL-8 in the CSDHs did not differ significantly in relation to either the age of the hematoma (measured as the interval from trauma) or the age of the patient.
CONCLUSIONS: Brain trauma causes the onset of an inflammatory process within the dural border cell layer; high levels of inflammatory cytokines were significantly correlated with recurrence and layering CSDH. A prolonged postoperative antiinflammatory medicine given as prophylaxis may help prevent the recurrence of a CSDH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743908     DOI: 10.3171/jns.2004.100.1.0024

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  52 in total

1.  Local and systemic pro-inflammatory and anti-inflammatory cytokine patterns in patients with chronic subdural hematoma: a prospective study.

Authors:  Milo Stanisic; Ansgar Oddne Aasen; Are Hugo Pripp; Karl-Fredrik Lindegaard; Jon Ramm-Pettersen; Staale Petter Lyngstadaas; Jugoslav Ivanovic; Ane Konglund; Eivind Ilstad; Tiril Sandell; Omar Ellingsen; Terje Sæhle
Journal:  Inflamm Res       Date:  2012-04-19       Impact factor: 4.575

2.  Clinical analysis of risk factors related to recurrent chronic subdural hematoma.

Authors:  Byung-Soo Ko; Jung-Kil Lee; Bo-Ra Seo; Sung-Jun Moon; Jae-Hyoo Kim; Soo-Han Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-01-20

Review 3.  Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature.

Authors:  Akira Tempaku; Shigeru Yamauchi; Hidetoshi Ikeda; Nobuyuki Tsubota; Hironori Furukawa; Daisuke Maeda; Kimito Kondo; Akimasa Nishio
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

4.  Impact of aging on the immune response to traumatic brain injury (AIm:TBI) study protocol.

Authors:  Hilaire J Thompson; Frederick Rivara; Kyra J Becker; Ronald Maier; Nancy Temkin
Journal:  Inj Prev       Date:  2019-09-03       Impact factor: 2.399

5.  The efficacy and safety of burr-hole craniotomy without continuous drainage for chronic subdural hematoma and subdural hygroma in children under 2 years of age.

Authors:  Kazuya Matsuo; Nobuyuki Akutsu; Kunitoshi Otsuka; Kazuki Yamamoto; Atsufumi Kawamura; Tatsuya Nagashima
Journal:  Childs Nerv Syst       Date:  2016-09-09       Impact factor: 1.475

6.  Procollagen propeptides in chronic subdural hematoma reveal sustained dural collagen synthesis after head injury.

Authors:  Anna-Leena Heula; Juha Sajanti; Kari Majamaa
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

7.  Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma.

Authors:  Tsukasa Wada; Kiyoshi Kuroda; Yuki Yoshida; Kuniaki Ogasawara; Akira Ogawa; Shigeatsu Endo
Journal:  Neurosurg Rev       Date:  2006-03-10       Impact factor: 3.042

Review 8.  Management of Subdural Hematomas: Part I. Medical Management of Subdural Hematomas.

Authors:  Elena I Fomchenko; Emily J Gilmore; Charles C Matouk; Jason L Gerrard; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

9.  An association of low high-density lipoprotein levels with recurrence of chronic subdural hematoma.

Authors:  Wen-Chao Liu; Qing-Qing Lin; Jing Jin; Ming Wang; Wen-Dong You; Jun Gu; Jian-Wei Pan
Journal:  Acta Neurochir (Wien)       Date:  2020-11-04       Impact factor: 2.216

10.  Vascular endothelial growth factor concentration in chronic subdural hematoma fluid is related to computed tomography appearance and exudation rate.

Authors:  Ralf Weigel; Axel Hohenstein; Lothar Schilling
Journal:  J Neurotrauma       Date:  2014-01-17       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.